Cardinal Health

Pharmacy screening for chronic obstructive pulmonary disease (COPD)

Setting up spirometry screening

Smoking cessation strategy implemented in pharmacies throughout the UK

BFG Healthcare Marketing worked with spirometry systems manufacturer Cardinal Health to look at the feasibility of pharmacies screening for chronic obstructive pulmonary disease (COPD).

COPD affects more than 3 million people and is the second largest cause of emergency hospital admissions in the UK. BFG Healthcare Marketing undertook pilot trials of pharmacy screening to demonstrate how COPD flare-ups can be identified and monitored, helping to prevent hospitalisation.

Following the feasibility study, BFG Healthcare Marketing drafted a smoking cessation strategy to be implemented in pharmacies across the country. The strategy outlined how pharmacies could offer COPD spirometory screening to help identify sufferers, along with a smoking cessation programme that would help smokers quit.

The strategy included a full financial analysis and implementation strategy and led to a chain of 100 supermarket pharmacies introducing a screening programme using Cardinal Health’s spirometers.

Project Details


Cardinal Health

Projects commissioned

Market opportunity analysis
Competitor analysis
Sales and marketing strategy

Share this story

Share on linkedin
Share on twitter
Share on facebook
Share on google
Share on pinterest
Share on email
BFG Healthcare logo

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.